stockportfolio.pro
Solventum Corporation (SOLV)
Healthcare · Medical Instruments & Supplies · NYSE
Solventum Corporation revenue & earnings — last 4 fiscal years
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $8.13B | $8.20B | $8.25B | $8.32B |
| Gross profit | $4.70B | $4.69B | $4.59B | $4.45B |
| Net income | $1.34B | $1.35B | $479.00M | $1.56B |
| Net margin | 16.5% | 16.4% | 5.8% | 18.7% |
Source: Solventum Corporation SEC filings (10-K).
Explore 4 years of Solventum Corporation financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track SOLV in your portfolio →
Solventum Corporation financial history by metric
About Solventum Corporation
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.
Solventum Corporation — frequently asked questions
What is Solventum Corporation's revenue?
Solventum Corporation (SOLV) reported revenue of $8.32B for fiscal year 2025, up 0.9% from the prior year, according to its SEC filings.
Is Solventum Corporation profitable?
Yes. SOLV earned net income of $1.56B in fiscal 2025, a net margin of 18.7%.
What is SOLV's P/E ratio?
Solventum Corporation trades at a price-to-earnings ratio of about 10.1 based on the latest data in our nightly-refreshed cache.
How fast is Solventum Corporation growing?
SOLV's revenue grew at roughly 0.8% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does Solventum Corporation have?
As of fiscal year 2025, SOLV carried roughly $5.04B in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Solventum Corporation's gross margin?
SOLV's gross margin was 53.5% in fiscal 2025 — gross profit of $4.45B on revenue of $8.32B.
What is Solventum Corporation's market cap?
Solventum Corporation (SOLV) has a market capitalization of about $14.28B, based on the latest data in our nightly-refreshed cache.
When does Solventum Corporation's fiscal year end?
SOLV's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
Where does this data come from?
All figures are computed from Solventum Corporation's official SEC filings (10-K and 10-Q), covering 4 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.